Emergent BioSolutions Inc.
NYSE:EBS
7.52 (USD) • At close September 6, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,049.3 | 1,120.9 | 1,792.7 | 1,555.4 | 1,106 | 782.4 | 560.873 | 488.782 | 522.789 | 450.138 | 312.745 | 281.888 | 273.384 | 286.171 | 234.786 | 178.554 | 182.915 | 152.732 | 130.688 | 83.494 | 55.769 | 78.541 | 45.309 |
| Cost of Revenue
| 756.8 | 693.7 | 757.5 | 524 | 433.5 | 322.3 | 195.707 | 131.284 | 124.295 | 118.412 | 62.127 | 46.077 | 42.171 | 47.114 | 46.262 | 34.081 | 40.309 | 24.125 | 31.603 | 30.102 | 0 | 24.569 | 424.1 |
| Gross Profit
| 292.5 | 427.2 | 1,035.2 | 1,031.4 | 672.5 | 460.1 | 365.166 | 357.498 | 398.494 | 331.726 | 250.618 | 235.811 | 231.213 | 239.057 | 188.524 | 144.473 | 142.606 | 128.607 | 99.085 | 53.392 | 55.769 | 53.972 | -378.791 |
| Gross Profit Ratio
| 0.279 | 0.381 | 0.577 | 0.663 | 0.608 | 0.588 | 0.651 | 0.731 | 0.762 | 0.737 | 0.801 | 0.837 | 0.846 | 0.835 | 0.803 | 0.809 | 0.78 | 0.842 | 0.758 | 0.639 | 1 | 0.687 | -8.36 |
| Reseach & Development Expenses
| 107.8 | 193 | 234 | 234.5 | 226.2 | 142.8 | 97.384 | 108.29 | 153.997 | 150.829 | 119.933 | 120.226 | 124.832 | 89.295 | 74.588 | 59.47 | 53.958 | 45.501 | 18.381 | 10.117 | 0 | 2.808 | 193 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 202.5 | 143.497 | 143.686 | 148.458 | 122.841 | 87.883 | 76.018 | 0 | 76.205 | 73.786 | 55.076 | 55.555 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 356.7 | 340.3 | 348.4 | 303.3 | 273.5 | 202.5 | 143.497 | 143.686 | 148.458 | 122.841 | 87.883 | 76.018 | 74.282 | 76.205 | 73.786 | 55.076 | 55.555 | 44.601 | 42.793 | 30.323 | 0 | 13.397 | 340.3 |
| Other Expenses
| 8.9 | 59.9 | 58.5 | 59.8 | 58.7 | 1.6 | -0.815 | 0.263 | -0.319 | 2.926 | 0.426 | 1.97 | 0 | 0 | 0 | 0 | 0 | 16.575 | -10 | 0 | 0 | 0 | 336.2 |
| Operating Expenses
| 464.5 | 593.2 | 640.9 | 597.6 | 558.4 | 370.3 | 240.881 | 251.976 | 302.455 | 273.67 | 207.816 | 196.244 | 199.114 | 165.5 | 148.374 | 114.546 | 109.513 | 90.102 | 51.174 | 40.44 | 0 | 16.205 | 869.5 |
| Operating Income
| -172 | -166 | 352.6 | 433.8 | 114.1 | 89.8 | 124.285 | 105.522 | 96.039 | 58.056 | 42.802 | 29.967 | 32.099 | 73.557 | 40.15 | 29.927 | 33.093 | 38.028 | 21.336 | 16.771 | 55.769 | 37.767 | -0.364 |
| Operating Income Ratio
| -0.164 | -0.148 | 0.197 | 0.279 | 0.103 | 0.115 | 0.222 | 0.216 | 0.184 | 0.129 | 0.137 | 0.106 | 0.117 | 0.257 | 0.171 | 0.168 | 0.181 | 0.249 | 0.163 | 0.201 | 1 | 0.481 | -0.008 |
| Total Other Income Expenses Net
| -559.2 | -55.7 | -38.2 | -26.6 | -36.7 | 1.6 | -0.815 | 0.263 | -0.319 | 2.926 | 0.426 | -7.63 | -0.261 | -1.023 | -0.05 | 0.134 | 0.156 | -0.184 | -16.52 | 3.827 | 0 | -0.271 | -0.119 |
| Income Before Tax
| -731.2 | -221.7 | 314.4 | 407.2 | 77.4 | 81.5 | 118.633 | 99.221 | 89.769 | 53.062 | 43.367 | 32.065 | 31.943 | 73.366 | 41.511 | 32.737 | 35.987 | 38.015 | 21.109 | 16.601 | 0 | 37.125 | -0.554 |
| Income Before Tax Ratio
| -0.697 | -0.198 | 0.175 | 0.262 | 0.07 | 0.104 | 0.212 | 0.203 | 0.172 | 0.118 | 0.139 | 0.114 | 0.117 | 0.256 | 0.177 | 0.183 | 0.197 | 0.249 | 0.162 | 0.199 | 0 | 0.473 | -0.012 |
| Income Tax Expense
| 29.3 | 2.1 | 83.5 | 102.1 | 22.9 | 18.8 | 36.039 | 36.697 | 26.899 | 16.321 | 13.108 | 13.922 | 15.83 | 26.182 | 14.966 | 12.055 | 13.051 | 15.222 | 5.325 | 5.129 | -4.454 | 0.733 | 2.1 |
| Net Income
| -760.5 | -223.8 | 219.5 | 305.8 | 54.5 | 62.7 | 82.594 | 51.776 | 62.87 | 36.741 | 31.135 | 23.524 | 23.019 | 51.698 | 31.144 | 20.682 | 22.936 | 22.793 | 15.784 | 11.472 | 4.454 | 36.392 | -0.554 |
| Net Income Ratio
| -0.725 | -0.2 | 0.122 | 0.197 | 0.049 | 0.08 | 0.147 | 0.106 | 0.12 | 0.082 | 0.1 | 0.083 | 0.084 | 0.181 | 0.133 | 0.116 | 0.125 | 0.149 | 0.121 | 0.137 | 0.08 | 0.463 | -0.012 |
| EPS
| -14.85 | -4.47 | 4.1 | 5.79 | 1.06 | 1.25 | 1.98 | 1.29 | 1.63 | 0.98 | 0.86 | 0.65 | 0.65 | 1.63 | 1.02 | 0.69 | 0.79 | 0.99 | 0.77 | 0.61 | 0.24 | 1.97 | -0.03 |
| EPS Diluted
| -14.85 | -4.47 | 4.06 | 5.67 | 1.04 | 1.22 | 1.71 | 1.13 | 1.41 | 0.88 | 0.85 | 0.65 | 0.64 | 1.59 | 0.99 | 0.68 | 0.77 | 0.93 | 0.69 | 0.56 | 0.22 | 1.75 | -0.03 |
| EBITDA
| -42.9 | -34.4 | 514.4 | 553 | 226.5 | 116.4 | 125.223 | 106.838 | 131.627 | 93.755 | 62.325 | 52.868 | 41.559 | 80.379 | 46.567 | 34.757 | 37.754 | 43.404 | 67.98 | 10.992 | 55.769 | 38.038 | 45.428 |
| EBITDA Ratio
| -0.041 | -0.031 | 0.287 | 0.356 | 0.205 | 0.149 | 0.223 | 0.219 | 0.252 | 0.208 | 0.199 | 0.188 | 0.152 | 0.281 | 0.198 | 0.195 | 0.206 | 0.284 | 0.52 | 0.132 | 1 | 0.484 | 1.003 |